BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Krawczyk M, Mihalache F, Höblinger A, Acalovschi M, Lammert F, Zimmer V. Pancreatic cancer risk variant ABO rs505922 in patients with cholangiocarcinoma. World J Gastroenterol 2011; 17(41): 4640-4642 [PMID: 22147973 DOI: 10.3748/wjg.v17.i41.4640]
URL: https://www.wjgnet.com/1007-9327/full/v17/i41/4640.htm
Number Citing Articles
1
Seth K Rummel, Rachel E Ellsworth. The role of the histoblood ABO group in cancerFuture Science OA 2016; 2(2) doi: 10.4155/fsoa-2015-0012
2
Guanwu Wang, Lara Rosaline Heij, Dong Liu, Edgar Dahl, Sven Arke LANG, Tom Florian Ulmer, Tom LUEDDE, Ulf Peter Neumann, Jan Bednarsch. The Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic ReviewCancers 2022; 14(23): 5969 doi: 10.3390/cancers14235969
3
Yanxia Li, Luyang Liu, Yubei Huang, Hong Zheng, Lian Li. Association of ABO polymorphisms and pancreatic Cancer/ Cardiocerebrovascular disease: a meta-analysisBMC Medical Genetics 2020; 21(1) doi: 10.1186/s12881-020-0975-8
4
Yanling Ying, Jingjing Zhang, Xiaozhen Hong, Wenjing Yuan, Kairong Ma, Xinyu Huang, Xianguo Xu, Faming Zhu. Comprehensive Annotation of Complete ABO Alleles and Resolution of ABO Variants by an Improved Full-Length ABO Haplotype SequencingClinical Chemistry 2025; 71(4): 510 doi: 10.1093/clinchem/hvaf015
5
Yun-Fei Duan, Feng Zhu, Xiao-Dong Li, Yong An, Hanze Zhang, Yebin Zhou, Xiaofei Zhang, Yong Jiang. Association between ABO gene polymorphism (rs505922) and cancer risk: a meta-analysisTumor Biology 2015; 36(7): 5081 doi: 10.1007/s13277-015-3159-y